Congratulations to our masters graduate, Kaylee Molin, for publishing her research in the @ACPSEM journal!
Her study highlights #clinical features as key survival predictors in advanced #prostateCancer.
Well done Kaylee!
@ACPSEM@UWAresearch#MedPhys
https://t.co/juGkmzFRMl
AANMS Theranostics course series #2!
Join us for an interactive case based session on Neuroendocrine neoplasia with @DrDavePattison@NattakornKnight!
23rd October 1930 AEDT.
Scan QR code to add to calendar (but please double check the event time due to time zones) 📅
New paper suggesting ADT modulates PSMA uptake in normal organs: decreased salivary, liver, spleen and kidney uptake. https://t.co/fTu2CYlVas @JournalofNucMed
👉Last minute reminder - AANMS Theranostics online
course starts in a few hours - tonight 7.30pm AEST.
👉Please join our interactive session on Prostate
Cancer with an expert panel.
👉QR code and zoom link attached
#nuclearmedicine#theransotics
Our @PCF_Science@pros_tic Webinar is coming up this Wed/Thurs...
Join >600 already registered for free: https://t.co/3taxayUWBq
Featuring @DrDavePattison talking about the first-in-class Pb-212 ADVC001 alpha PSMA study in prostate cancer
⭐Dont miss this webinar - the first of our quarterly
interactive sessions.
⭐Ask our expert panel online questions and
participate in the polls.
⭐Log in via the link or QR code.
⭐Monday 17 July 2023, 7.30 pm (AEST)
#nuclearmedicine#theranostics
AANMS Theranostics course series #1!
Join us for an interactive case based session on PSMA theranostics with @DrMHofman@drlouiseemmett@NattakornKnight @bonnialiu!
17th July 1930 AEST.
Use the QR code to add the event link to your calendar 📅.
@TheranosticsAus@AusNucMed
Instructive ana reassuring paper, should not be deterred from offering an effective therapy in even severe renal failure. Just make sure to relieve the obstruction before treatment though.
The new PSG score is a PSMA-PET Whole-Body Tumor-to-Salivary Gland Ratio to estimate the target expression at the whole body level using the PET MIP to Predict Response to 177Lu-PSMA (PLUVICTO). Tested by 10 international experts on 237 patients. https://t.co/pfr95zMar7